AI
AI accelerates Alzheimer's research into genetic targets
By age 65, almost all individuals with two copies of the APOE4 gene variant had abnormal levels of the Alzheimer's biomarker amyloid beta in their cerebrospinal fluid, according to NIH .
Arjun Mehta·April 22, 2026
